Masters Access

Improving patients’ quality of life through early access to advanced medicines and treatments. 

Our knowledge and experience in Emerging Markets set us apart from our competitors. Our own teams located in these areas work with Key Opinion Leaders (KOLs) and Patient Advocacy Groups, to understand the unfulfilled needs within a specific disease area, including rare and orphan diseases.

We enable patients to access the medicines and treatments they need when they need them; even if the products are not yet available in their markets.

Masters are the trusted link for access to medicines through; 

  • Early Access Programmes
  • Education through a series of scientific meetings with Key Opinion Leaders
  • Local Disease Management and Patient Assistance Programmes through our partnerships with Patient Advocacy Groups.

Related content

Improving patients’ quality of life through expanded access to advanced medications. Our knowledge and experience in the Emerging Markets sets us apart from our competitors. Our own teams located in these areas work with Key Opinion Leaders (KOL) and Patient Advocacy Groups, to understand the unfulfilled needs within a specific disease area, with a focus on rare and orphan diseases.
Improving patients’ quality of life through expanded access to advanced medications. Our knowledge and experience in the Emerging Markets sets us apart from our competitors. Our own teams located in these areas work with Key Opinion Leaders (KOL) and Patient Advocacy Groups, to understand the unfulfilled needs within a specific disease area, with a focus on rare and orphan diseases.

Masters On-Demand

Our reputation and values are bound by ethics and bonafide sourcing from our select network of reliable and trusted partners. We deliver innovative speciality medicines that are yet to be locally registered, have been discontinued, or are in short supply.

We guarantee product integrity through safe and efficient supply chain distribution of medicinal products through our centres in the UK, USA, Central America, South America, Middle East, and Europe.

  • Quality Assured
  • Full Batch Traceability
  • Cold Chain and Controlled Products
  • Pharmacovigilance

Most importantly – patient well-being is at the forefront of our minds.


Related content

Masters Partnering

Our partners trust in our proven capabilities to distribute their specialist drugs, cold-chain medicines, and controlled substances; ensuring product quality and integrity end to end, including the very last mile.

In-house:

  • Medical
  • Regulatory
  • QMS
  • Pharmacovigilance

Exclusive distribution agreements with our partners in the UK, US, and Europe:
Partner with Masters and benefit from extensive experience in the supply of specialist medicines to the most remote parts of the world.

Masters Portfolio: We know the intricacies of introducing and launching medicines to complex and challenging markets. This includes navigating difficult and often lengthy regulatory and approval processes. We do this through:

  • Regional subsidiaries with local Business Development teams.
  • Knowledge of local market dynamics including; pricing, reimbursement, and tenders.
  • In-house regulatory teams with local knowledge and requirements.
  • In-house global marketing and medical information teams, to effectively launch with correct placement.

We deliver excellence where there is complexity.


Related content

Masters Portfolio

Our expertise in Emerging Markets makes us the right choice of partner for managing your innovative products in these complex and challenging areas.

We understand the complexities in bringing medicines to new markets, and over the last 35 years, we have built the knowledge and capabilities to deal with the difficult and often lengthy registration and approval processes. This is where our ‘on the ground’ local expertise and global regulatory capabilities come into their own.

  • Extensive knowledge of International competitor landscapes, branded and generic products, and across a number of key therapeutic areas.
  • Regional subsidiaries with their own Business Development teams, for local support.
  • Insight into market dynamics including; pricing, local reimbursement, and tenders.
  • In-house regulatory teams with local knowledge and requirements.
  • In-house global marketing and medical information teams, to effectively launch and ensure correct placement.

We deliver excellence where there is complexity.


Related content